Last reviewed 2026-04-22 · How we verify

Ropivacaine Hydrocloride

Ropivacaine hydrochloride is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Ropivacaine hydrochloride is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses. Used for Local and regional anesthesia for surgical procedures, Acute pain management via peripheral nerve blocks, Epidural anesthesia.

At a glance

Mechanism of action

As an amide-type local anesthetic, ropivacaine selectively inhibits sodium influx into nerve fibers, which stabilizes the neuronal membrane and prevents depolarization. This action reversibly blocks pain signal transmission along peripheral nerves. Ropivacaine is structurally similar to bupivacaine but has a lower propensity for cardiotoxicity and central nervous system toxicity.

Approved indications

• Local and regional anesthesia for surgical procedures
• Acute pain management via peripheral nerve blocks
• Epidural anesthesia

Common side effects

• Hypotension
• Bradycardia
• Nausea
• Headache
• Dizziness
• Neurological toxicity (at high doses)

Key clinical trials

• SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty (NA)
• Parturient Satisfaction With Epidural Analgesia by PCEA or Manual Boluses
• QLB and Laparoscopic Nephrectomy, Postoperative Pain and Recovery (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Ropivacaine Hydrocloride CI brief — competitive landscape report
• Ropivacaine Hydrocloride updates RSS · CI watch RSS
• Women's Hospital HUS portfolio CI